We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAP icon
1251
Advance Auto Parts
AAP
$3.23B
$17.9M ﹤0.01%
86,588
-9,234
-10% -$2.03M
JNPR
1252
DELISTED
Juniper Networks
JNPR
$17.9M ﹤0.01%
481,882
-29,428
-6% -$1.01M
MAS icon
1253
Masco
MAS
$14.7B
$17.9M ﹤0.01%
350,834
-22,011
-6% -$1.31M
SWTX
1254
DELISTED
SpringWorks Therapeutics
SWTX
$17.8M ﹤0.01%
315,442
+3,401
+1% +$195K
EVTC icon
1255
Evertec
EVTC
$1.91B
$17.6M ﹤0.01%
429,480
+404,056
+1,589% +$17.3M
NDSN icon
1256
Nordson
NDSN
$17.3B
$17.4M ﹤0.01%
76,719
+56,930
+288% +$13.1M
NET icon
1257
Cloudflare
NET
$118B
$17.4M ﹤0.01%
145,119
+8,302
+6% +$866K
FFIV icon
1258
F5
FFIV
$24B
$17.3M ﹤0.01%
82,643
-5,160
-6% -$1.08M
FAF icon
1259
First American
FAF
$7.38B
$17.2M ﹤0.01%
265,872
+3,722
+1% +$265K
HII icon
1260
Huntington Ingalls Industries
HII
$12.9B
$17.2M ﹤0.01%
86,347
-17,138
-17% -$3.34M
RGCO icon
1261
RGC Resources
RGCO
$225M
$17.2M ﹤0.01%
805,036
+200,000
+33% +$4.4M
ABEV icon
1262
Ambev
ABEV
$43.5B
$17.1M ﹤0.01%
5,300,200
+513,900
+11% +$1.44M
CYTK icon
1263
Cytokinetics
CYTK
$10.5B
$17M ﹤0.01%
462,483
+313,044
+209% +$11.1M
WEX icon
1264
WEX
WEX
$6.48B
$17M ﹤0.01%
95,365
+373
+0.4% +$60.8K
SITM icon
1265
SiTime
SITM
$20.7B
$17M ﹤0.01%
68,485
-43,485
-39% -$9.43M
ARNC
1266
DELISTED
Arconic Corporation
ARNC
$16.9M ﹤0.01%
661,050
+4,773
+0.7% +$142K
SANA icon
1267
Sana Biotechnology
SANA
$1.1B
$16.9M ﹤0.01%
2,050,133
+845,437
+70% +$6.84M
FBNC icon
1268
First Bancorp
FBNC
$2.72B
$16.8M ﹤0.01%
402,776
-177,200
-31% -$7.91M
MRCY icon
1269
Mercury Systems
MRCY
$6.7B
$16.8M ﹤0.01%
260,101
+105,628
+68% +$6.27M
AAL icon
1270
American Airlines Group
AAL
$9.97B
$16.8M ﹤0.01%
917,997
-69,143
-7% -$1.18M
PHM icon
1271
Pultegroup
PHM
$24.6B
$16.7M ﹤0.01%
399,331
-2,095
-0.5% -$104K
SUPN icon
1272
Supernus Pharmaceuticals
SUPN
$2.78B
$16.7M ﹤0.01%
516,227
-694
-0.1% -$21.3K
BLKB icon
1273
Blackbaud
BLKB
$2.1B
$16.6M ﹤0.01%
277,847
-100,532
-27% -$6.56M
RGLD icon
1274
Royal Gold
RGLD
$19.1B
$16.5M ﹤0.01%
116,755
+29,434
+34% +$3.44M
GDDY icon
1275
GoDaddy
GDDY
$12.7B
$16.4M ﹤0.01%
196,392
-3,440
-2% -$272K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.